No floor votes have been cast in the full chamber.
The bill would tie prescription drug prices to some foreign markets, though not single-payer nations. Drug companies would be compelled to disclose sensitive pricing data. It adopts more limited pricing and coverage rules. The bill freezes drug formularies and requires more reporting from insurance companies and state agencies. The bill also regulates pharmacy benefit managers and prevents them from dictating some dispensing and pricing benchmarks.
Vote Yes on this bill if you want to increase the accessibility and affordability of prescription drugs for Floridians by implementing international reference-based pricing.
Organizations that support this bill may include those advocating for increased medication adherence and competitive, market-based drug pricing in Florida.
Vote No on this bill if you want to maintain the current drug pricing and pharmacy benefit manager practices without added regulatory intervention.
Organizations that oppose this bill may include pharmacy benefit managers and drug manufacturers who are resistant to regulatory changes in drug pricing and reimbursement structures.
No floor votes have been cast in the full chamber.
No floor votes have been cast in the full chamber.